The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.

Compared with no dexamethasone treatment, early administration of dexamethasone in children with pneumococcal meningitis lowered 30-day all-cause mortality by 50%, a new study showed. Overall ...

During culture the distribution of acetate changed (decrease into PC ... and were not prevented by the presence of T 3 plus dexamethasone. In fibroblasts (87% pure) choline incorporation increased ...